Close

Thermo Fisher Scientific Completes Acquisition of Finesse Solutions, Inc

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

CDMO Market For Small Molecule Innovation Soars By 2033

It has been anticipated that the market for contract...

API Sourcing Redefining Global Pharmaceutical Supply Chain

The COVID-19 pandemic went on to expose crucial susceptibility...

Pharmaceutical Fine Chemicals Market to hit $235bn by 2030

The pharmaceutical fine chemicals market is all set for...

The Overall Spectrum Study of the Global HPAPI Market

High-potency active pharmaceutical ingredients - HPAPIs happen to represent...

Thermo Fisher Scientific Inc, the world leader in serving science completed its previously announced acquisition of Finesse Solutions, Inc., a leader in the development of scalable control automation systems and software for bioproduction.

The business will be integrated into Thermo Fisher’s Life Sciences Solutions Segment. Terms of the transaction were not disclosed.Based in Santa Clara, California, Finesse Solutions is a leader in bioprocess management technology, generating approximately $50 million in revenue in 2016. Its proprietary Smart™ technology, which consists of sensors, controllers and software, is designed to optimize the bioproduction workflow. The company has been a technology partner of Thermo Fisher Scientific since 2013.

About Thermo Fisher Scientific 
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com

Contact:Thermo Fisher Scientific

Media
Ron O’Brien, 781-622-1242
ron.obrien@thermofisher.com 
www.thermofisher.com 

or

Investors
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com

 

Latest stories

Related stories

CDMO Market For Small Molecule Innovation Soars By 2033

It has been anticipated that the market for contract...

API Sourcing Redefining Global Pharmaceutical Supply Chain

The COVID-19 pandemic went on to expose crucial susceptibility...

Pharmaceutical Fine Chemicals Market to hit $235bn by 2030

The pharmaceutical fine chemicals market is all set for...

The Overall Spectrum Study of the Global HPAPI Market

High-potency active pharmaceutical ingredients - HPAPIs happen to represent...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back